|
DE3689598T2
(de)
|
1985-01-28 |
1994-06-30 |
Xoma Corp |
Arab-promoter und verfahren zur herstellung von polypeptiden einschliesslich cecropinen mittels mikrobiologischer verfahren.
|
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
IN165717B
(enExample)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5202238A
(en)
|
1987-10-27 |
1993-04-13 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
|
US6004781A
(en)
|
1988-01-22 |
1999-12-21 |
The General Hospital Corporation |
Nucleic acid encoding Ig-CD4 fusion proteins
|
|
IL86278A
(en)
|
1988-05-04 |
2003-06-24 |
Yeda Res & Dev |
Endowing cells with antibody specificity using chimeric t cell receptor
|
|
US5906936A
(en)
|
1988-05-04 |
1999-05-25 |
Yeda Research And Development Co. Ltd. |
Endowing lymphocytes with antibody specificity
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US6406697B1
(en)
|
1989-02-23 |
2002-06-18 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US5216132A
(en)
|
1990-01-12 |
1993-06-01 |
Protein Design Labs, Inc. |
Soluble t-cell antigen receptor chimeric antigens
|
|
US20020004052A1
(en)
|
1990-05-08 |
2002-01-10 |
David Berd |
Composition comprising a tumor cell extract and method of using the composition
|
|
US5914109A
(en)
|
1990-06-15 |
1999-06-22 |
New York University |
Heterohybridomas producing human monoclonal antibodies to HIV-1
|
|
US20020111474A1
(en)
|
1990-12-14 |
2002-08-15 |
Capon Daniel J. |
Chimeric chains for receptor-associated signal transduction pathways
|
|
US6407221B1
(en)
|
1990-12-14 |
2002-06-18 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
|
US6319494B1
(en)
|
1990-12-14 |
2001-11-20 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
|
DE69123241T2
(de)
|
1990-12-14 |
1997-04-17 |
Cell Genesys Inc |
Chimärische ketten zur transduktion von rezeptorverbundenen signalwegen
|
|
US6753162B1
(en)
|
1991-03-07 |
2004-06-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
IL101147A
(en)
|
1991-03-07 |
2004-06-20 |
Gen Hospital Corp |
Redirection of cellular immunity by receptor chimeras
|
|
US5851828A
(en)
|
1991-03-07 |
1998-12-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
US5912170A
(en)
|
1991-03-07 |
1999-06-15 |
The General Hospital Corporation |
Redirection of cellular immunity by protein-tyrosine kinase chimeras
|
|
US7049136B2
(en)
|
1991-03-07 |
2006-05-23 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
|
US5843728A
(en)
|
1991-03-07 |
1998-12-01 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
|
US6004811A
(en)
|
1991-03-07 |
1999-12-21 |
The Massachussetts General Hospital |
Redirection of cellular immunity by protein tyrosine kinase chimeras
|
|
WO1992015671A1
(en)
|
1991-03-08 |
1992-09-17 |
Cytomed, Inc. |
Soluble cd28 proteins and methods of treatment therewith
|
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
|
AU2883192A
(en)
|
1991-10-21 |
1993-05-21 |
Cell Genesys, Inc. |
Combined cellular and immunosuppressive therapies
|
|
US8211422B2
(en)
|
1992-03-18 |
2012-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric receptor genes and cells transformed therewith
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
US5372930A
(en)
|
1992-09-16 |
1994-12-13 |
The United States Of America As Represented By The Secretary Of The Navy |
Sensor for ultra-low concentration molecular recognition
|
|
DK0668777T3
(da)
|
1992-11-05 |
2007-02-19 |
Sloan Kettering Inst Cancer |
Prostataspecifikt membran-antigen
|
|
US6953668B1
(en)
|
1992-11-05 |
2005-10-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US7105159B1
(en)
|
1992-11-05 |
2006-09-12 |
Sloan-Kettering Institute For Cancer Research |
Antibodies to prostate-specific membrane antigen
|
|
US5861156A
(en)
|
1993-01-08 |
1999-01-19 |
Creative Biomolecules |
Methods of delivering agents to target cells
|
|
US5747292A
(en)
|
1993-04-06 |
1998-05-05 |
Fred Hutchinson Cancer Research Center |
Chimeric cytokine receptors in lymphocytes
|
|
US6051427A
(en)
|
1993-06-11 |
2000-04-18 |
Cell Genesys, Inc. |
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
|
|
US5834256A
(en)
|
1993-06-11 |
1998-11-10 |
Cell Genesys, Inc. |
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
|
|
US5525503A
(en)
|
1993-09-28 |
1996-06-11 |
Dana-Farber Cancer Institute, Inc. |
Signal transduction via CD28
|
|
US5935818A
(en)
|
1995-02-24 |
1999-08-10 |
Sloan-Kettering Institute For Cancer Research |
Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof
|
|
EP0758394B1
(en)
|
1994-05-02 |
2002-11-20 |
Bernd Groner |
Bifunctional protein, preparation and use
|
|
US7354587B1
(en)
|
1994-07-06 |
2008-04-08 |
Immunomedics, Inc. |
Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
|
|
US5798100A
(en)
|
1994-07-06 |
1998-08-25 |
Immunomedics, Inc. |
Multi-stage cascade boosting vaccine
|
|
US5716614A
(en)
|
1994-08-05 |
1998-02-10 |
Molecular/Structural Biotechnologies, Inc. |
Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
|
|
WO1996013584A1
(en)
|
1994-11-01 |
1996-05-09 |
Targeted Genetics Corporation |
Chimeric receptors for the generation of selectively-activatable th-independent cytotoxic t cells
|
|
US5837544A
(en)
|
1995-02-02 |
1998-11-17 |
Cell Genesys, Inc. |
Method of inducing a cell to proliferate using a chimeric receptor comprising janus kinase
|
|
US5712149A
(en)
|
1995-02-03 |
1998-01-27 |
Cell Genesys, Inc. |
Chimeric receptor molecules for delivery of co-stimulatory signals
|
|
US6103521A
(en)
|
1995-02-06 |
2000-08-15 |
Cell Genesys, Inc. |
Multispecific chimeric receptors
|
|
JP2001526522A
(ja)
|
1995-02-24 |
2001-12-18 |
スローン−ケタリング・インスティテュート・フォー・キャンサー・リサーチ |
前立腺特異的膜抗原およびその使用
|
|
US5830755A
(en)
|
1995-03-27 |
1998-11-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
T-cell receptors and their use in therapeutic and diagnostic methods
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
GB9526131D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Recombinant chimeric receptors
|
|
US6451995B1
(en)
|
1996-03-20 |
2002-09-17 |
Sloan-Kettering Institute For Cancer Research |
Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
|
|
US6261787B1
(en)
|
1996-06-03 |
2001-07-17 |
Case Western Reserve University |
Bifunctional molecules for delivery of therapeutics
|
|
US5969102A
(en)
|
1997-03-03 |
1999-10-19 |
St. Jude Children's Research Hospital |
Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
|
|
US20020018783A1
(en)
|
1997-03-20 |
2002-02-14 |
Michel Sadelain |
Fusion proteins of a single chain antibody and cd28 and uses thereof
|
|
AU8142598A
(en)
|
1997-06-11 |
1998-12-30 |
New York University |
Prenylcysteine carboxyl methyltransferase, dna encoding same, and a method of screening for inhibitors thereof
|
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
|
US20090011984A1
(en)
|
1998-02-23 |
2009-01-08 |
Seppo Yla-Herttuala |
Biotin-binding receptor molecules
|
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
|
WO1999060120A2
(en)
|
1998-05-19 |
1999-11-25 |
Avidex Limited |
Soluble t cell receptor
|
|
WO2000014257A1
(en)
|
1998-09-04 |
2000-03-16 |
Sloan-Kettering Institute For Cancer Research |
Fusion receptors specific for prostate-specific membrane antigen and uses thereof
|
|
AU2472400A
(en)
|
1998-10-20 |
2000-05-08 |
City Of Hope |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
|
|
ATE370967T1
(de)
|
1998-10-21 |
2007-09-15 |
Altor Bioscience Corp |
Polyspezifische bindemoleküle und deren verwendung
|
|
US7217421B1
(en)
|
1998-11-03 |
2007-05-15 |
Cell Genesys, Inc. |
Cancer-associated antigens and methods of their identification and use
|
|
AU3389700A
(en)
|
1999-03-01 |
2000-09-21 |
Cell Genesys, Inc. |
Anti-neoplastic compositions and uses thereof
|
|
AU4418900A
(en)
|
1999-04-16 |
2000-11-02 |
Celltech Therapeutics Limited |
Synthetic transmembrane components
|
|
US6699972B1
(en)
|
1999-06-25 |
2004-03-02 |
Academia Sinica |
Chimeric protein and method of controlling tumor growth using the protein
|
|
IL150571A0
(en)
|
2000-01-03 |
2003-02-12 |
Tr Associates L L C |
Novel chimeric proteins and methods for using the same
|
|
AU2001236967A1
(en)
|
2000-02-14 |
2001-08-27 |
The Regents Of The University Of California |
Kidney-specific tumor vaccine directed against kidney tumor antigen g-250
|
|
US6770749B2
(en)
|
2000-02-22 |
2004-08-03 |
City Of Hope |
P53-specific T cell receptor for adoptive immunotherapy
|
|
EA005823B1
(ru)
|
2000-03-31 |
2005-06-30 |
Пердью Рисерч Фаундейшн |
Способ лечения с использованием конъюгатов лиганд-иммуноген
|
|
AU2001255580A1
(en)
|
2000-04-21 |
2001-12-11 |
Rutgers, The State University Of New Jersey |
Methods and compositions for the diagnosis of schizophrenia
|
|
US6524572B1
(en)
|
2000-06-26 |
2003-02-25 |
Rainbow Therapeutic Company |
Targeting recombinant virus with a bispecific fusion protein ligand in coupling with an antibody to cells for gene therapy
|
|
DE60133287T2
(de)
|
2000-07-31 |
2009-03-26 |
Green Peptide Co., Ltd., Kurume |
Tumorantigen
|
|
US7666424B2
(en)
|
2001-10-17 |
2010-02-23 |
Sloan-Kettering Institute For Cancer Research |
Methods of preparing and using single chain anti-tumor antibodies
|
|
ATE338124T1
(de)
|
2000-11-07 |
2006-09-15 |
Hope City |
Cd19-spezifische umgezielte immunzellen
|
|
US20020132983A1
(en)
|
2000-11-30 |
2002-09-19 |
Junghans Richard P. |
Antibodies as chimeric effector cell receptors against tumor antigens
|
|
US7723111B2
(en)
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
|
JP4448282B2
(ja)
|
2001-04-30 |
2010-04-07 |
シティ・オブ・ホープ |
ヒト癌を処置するのに有用なキメライムノレセプター
|
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
|
US7514537B2
(en)
|
2001-04-30 |
2009-04-07 |
City Of Hope |
Chimeric immunoreceptor useful in treating human gliomas
|
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
|
US20070031438A1
(en)
|
2001-12-10 |
2007-02-08 |
Junghans Richard P |
Antibodies as chimeric effector cell receptors against tumor antigens
|
|
US20030170238A1
(en)
|
2002-03-07 |
2003-09-11 |
Gruenberg Micheal L. |
Re-activated T-cells for adoptive immunotherapy
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
WO2004016643A2
(en)
|
2002-08-16 |
2004-02-26 |
Yeda Research And Development Co. Ltd. |
Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
|
|
AU2003265866A1
(en)
|
2002-09-03 |
2004-03-29 |
Vit Lauermann |
Targeted release
|
|
DE10244457A1
(de)
|
2002-09-24 |
2004-04-01 |
Johannes-Gutenberg-Universität Mainz |
Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren
|
|
AR038085A1
(es)
|
2002-12-27 |
2004-12-29 |
Univ Nac Quilmes |
Analogos de 1-desamino-8-d-arginina vasopresina
|
|
US20060018878A1
(en)
|
2003-03-11 |
2006-01-26 |
City Of Hope |
Dual antigen specific T cells with trafficking ability
|
|
US20050129671A1
(en)
|
2003-03-11 |
2005-06-16 |
City Of Hope |
Mammalian antigen-presenting T cells and bi-specific T cells
|
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
US20050113564A1
(en)
|
2003-11-05 |
2005-05-26 |
St. Jude Children's Research Hospital |
Chimeric receptors with 4-1BB stimulatory signaling domain
|
|
US7435596B2
(en)
|
2004-11-04 |
2008-10-14 |
St. Jude Children's Research Hospital, Inc. |
Modified cell line and method for expansion of NK cell
|
|
US20130266551A1
(en)
|
2003-11-05 |
2013-10-10 |
St. Jude Children's Research Hospital, Inc. |
Chimeric receptors with 4-1bb stimulatory signaling domain
|
|
US8652484B2
(en)
|
2004-02-13 |
2014-02-18 |
Immunomedics, Inc. |
Delivery system for cytotoxic drugs by bispecific antibody pretargeting
|
|
WO2005079836A1
(en)
|
2004-02-18 |
2005-09-01 |
Wisconsin Alumni Research Foundation |
Method for treating glaucoma
|
|
EP2044961B1
(en)
|
2004-03-02 |
2013-07-17 |
Cellectar, Inc. |
Phospholipid analogues for the treatment of pancreatic, ovarian and colon cancers, melanomas, gliomas, and carcinosarcomas
|
|
DE602005016683D1
(de)
|
2004-07-10 |
2009-10-29 |
Fox Chase Cancer Ct |
Genetisch modifizierte, menschliche, natürliche killerzellenlinien:
|
|
TWI309240B
(en)
|
2004-09-17 |
2009-05-01 |
Hoffmann La Roche |
Anti-ox40l antibodies
|
|
US7994298B2
(en)
|
2004-09-24 |
2011-08-09 |
Trustees Of Dartmouth College |
Chimeric NK receptor and methods for treating cancer
|
|
EP1809321B1
(en)
|
2004-10-08 |
2012-03-14 |
Government of the United States of America, Represented by the Secretary, Department of Health and Human Services |
Adoptive immunotherapy with enhanced t lymphocyte survival
|
|
CA2587766A1
(en)
|
2004-11-10 |
2007-03-01 |
Macrogenics, Inc. |
Engineering fc antibody regions to confer effector function
|
|
WO2007044033A2
(en)
|
2004-12-07 |
2007-04-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen
|
|
US20070036773A1
(en)
|
2005-08-09 |
2007-02-15 |
City Of Hope |
Generation and application of universal T cells for B-ALL
|
|
US8466263B2
(en)
|
2005-12-02 |
2013-06-18 |
Dana-Farber Cancer Institute, Inc. |
Carbonic anhydrase IX (G250) anitbodies
|
|
US7919079B2
(en)
|
2006-03-31 |
2011-04-05 |
Biosante Pharmaceuticals, Inc. |
Cancer immunotherapy compositions and methods of use
|
|
EP2418223A3
(en)
|
2006-06-12 |
2013-01-16 |
Emergent Product Development Seattle, LLC |
Single-chain multivalent binding proteins with effector function
|
|
US20090182127A1
(en)
|
2006-06-22 |
2009-07-16 |
Novo Nordisk A/S |
Production of Bispecific Antibodies
|
|
US20080051380A1
(en)
|
2006-08-25 |
2008-02-28 |
Auerbach Alan H |
Methods and compositions for treating cancer
|
|
EP1900752A1
(en)
|
2006-09-15 |
2008-03-19 |
DOMPE' pha.r.ma s.p.a. |
Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
|
|
US20100105136A1
(en)
|
2006-10-09 |
2010-04-29 |
The General Hospital Corporation |
Chimeric t-cell receptors and t-cells targeting egfrviii on tumors
|
|
US9334330B2
(en)
|
2006-10-10 |
2016-05-10 |
Universite De Nantes |
Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers
|
|
CA2668197A1
(en)
|
2006-11-03 |
2008-05-15 |
Philip S. Low |
Ex vivo flow cytometry method and device
|
|
CA2667414C
(en)
|
2006-11-13 |
2015-12-29 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of the human glucocorticoid receptor locus
|
|
US20080131415A1
(en)
|
2006-11-30 |
2008-06-05 |
Riddell Stanley R |
Adoptive transfer of cd8 + t cell clones derived from central memory cells
|
|
US8748405B2
(en)
|
2007-01-26 |
2014-06-10 |
City Of Hope |
Methods and compositions for the treatment of cancer or other diseases
|
|
DE602008006041D1
(de)
|
2007-01-30 |
2011-05-19 |
Forerunner Pharma Res Co Ltd |
CHIMÄRER Fc GAMMA REZEPTOR UND VERFAHREN ZUR BESTIMMUNG VON ADCC-AKTIVITÄT UNTER VERWENDUNG DES REZEPTORS
|
|
HRP20161191T1
(hr)
|
2007-01-31 |
2016-11-18 |
Yeda Research And Development Company Limited |
Preusmjerene, genetski projektirane t regulacijske stanice i njihova uporaba u suspenziji autoimunih i upalnih bolesti
|
|
US8859229B2
(en)
|
2007-02-02 |
2014-10-14 |
Yale University |
Transient transfection with RNA
|
|
US8865169B2
(en)
|
2007-02-20 |
2014-10-21 |
Tufts University |
Methods and systems for multi-antibody therapies
|
|
EP2856876B1
(en)
|
2007-03-30 |
2018-01-31 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
|
|
JPWO2009020094A1
(ja)
|
2007-08-09 |
2010-11-04 |
第一三共株式会社 |
疎水性分子で修飾した抗体
|
|
WO2009091826A2
(en)
|
2008-01-14 |
2009-07-23 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car)
|
|
WO2009117117A1
(en)
|
2008-03-19 |
2009-09-24 |
Altor Bioscience Corporation |
T cell receptor fusions and conjugates and methods of use there of
|
|
DK2279253T3
(en)
|
2008-04-09 |
2017-02-13 |
Maxcyte Inc |
Construction and application of therapeutic compositions of freshly isolated cells
|
|
SG189772A1
(en)
|
2008-04-11 |
2013-05-31 |
Trubion Pharmaceuticals Inc |
Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
|
US20090324630A1
(en)
|
2008-04-21 |
2009-12-31 |
Jensen Michael C |
Fusion multiviral chimeric antigen
|
|
US8822647B2
(en)
|
2008-08-26 |
2014-09-02 |
City Of Hope |
Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cells
|
|
CA2737496A1
(en)
|
2008-09-17 |
2010-03-25 |
Endocyte, Inc. |
Folate receptor binding conjugates of antifolates
|
|
CN102272327B
(zh)
|
2008-11-07 |
2015-11-25 |
赛昆塔公司 |
通过序列分析监测状况的方法
|
|
EP3936122A1
(en)
|
2008-11-24 |
2022-01-12 |
Massachusetts Institute Of Technology |
Methods and compositions for localized agent delivery
|
|
US20110178279A1
(en)
|
2009-08-03 |
2011-07-21 |
Williams John C |
Development of masked therapeutic antibodies to limit off-target effects: application to anti-egfr antibodies
|
|
US8877199B2
(en)
|
2009-05-15 |
2014-11-04 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
B cell surface reactive antibodies
|
|
US20100322909A1
(en)
|
2009-06-17 |
2010-12-23 |
The University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Th1-associated micrornas and their use for tumor immunotherapy
|
|
US8465743B2
(en)
|
2009-10-01 |
2013-06-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
|
|
BR112012009962A2
(pt)
|
2009-10-27 |
2015-09-15 |
Immunicum Ab |
método para a proliferação de células tantígeno específicas.
|
|
US9273283B2
(en)
|
2009-10-29 |
2016-03-01 |
The Trustees Of Dartmouth College |
Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
|
|
WO2011059836A2
(en)
|
2009-10-29 |
2011-05-19 |
Trustees Of Dartmouth College |
T cell receptor-deficient t cell compositions
|
|
CA2779526C
(en)
|
2009-11-03 |
2022-12-06 |
City Of Hope |
Truncated epiderimal growth factor receptor (egfrt) for transduced t cell selection
|
|
EP2698430A3
(en)
|
2009-12-08 |
2014-03-05 |
Wilson Wolf Manufacturing Corporation |
Methods of cell culture for adoptive cell therapy
|
|
US8956860B2
(en)
|
2009-12-08 |
2015-02-17 |
Juan F. Vera |
Methods of cell culture for adoptive cell therapy
|
|
WO2011094198A1
(en)
|
2010-01-28 |
2011-08-04 |
The Children's Hospital Of Philadelphia Research Institute, Abramson Research Center |
A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
|
|
CA2791975C
(en)
|
2010-02-04 |
2021-02-09 |
The Trustees Of The University Of Pennsylvania |
Icos critically regulates the expansion and function of inflammatory human th17 cells
|
|
AU2011215685B2
(en)
|
2010-02-12 |
2015-08-20 |
Oncomed Pharmaceuticals, Inc. |
Methods for identifying and isolating cells expressing a polypeptide
|
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
|
EP3725319A1
(en)
|
2010-04-14 |
2020-10-21 |
Roger Williams Medical Center |
Methods and compositions for treating hiv
|
|
ES2686424T5
(es)
|
2010-05-04 |
2023-03-27 |
Yeda Res & Dev |
Inmunoterapia con células alogénicas redireccionadas
|
|
WO2011146862A1
(en)
|
2010-05-21 |
2011-11-24 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing selective apoptosis
|
|
WO2011159847A2
(en)
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof
|
|
WO2012012695A2
(en)
|
2010-07-23 |
2012-01-26 |
Fred Hutchinson Cancer Research Center |
A method for the treatment of obesity
|
|
DE102010036122A1
(de)
|
2010-09-01 |
2012-03-01 |
Nora Systems Gmbh |
Bodenbelag
|
|
EP3467101A3
(en)
|
2010-09-08 |
2019-06-19 |
Baylor College of Medicine |
Immunotherapy of brain tumor using geneticially engineered gd2-specific t cells
|
|
ES2656414T3
(es)
|
2010-09-08 |
2018-02-27 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Receptores de antígenos quiméricos con una región bisagra optimizada
|
|
EP2614151B1
(en)
|
2010-09-08 |
2019-07-24 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Interleukin 15 as selectable marker for gene transfer in lymphocytes
|
|
EP3533802B1
(en)
|
2010-09-21 |
2021-03-17 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Anti-ssx-2 t cell receptors and related materials and methods of use
|
|
CN103154257A
(zh)
|
2010-09-26 |
2013-06-12 |
大玉企业有限公司 |
重组大分子生成方法
|
|
US9845362B2
(en)
|
2010-10-08 |
2017-12-19 |
The University Of North Carolina At Charlotte |
Compositions comprising chimeric antigen receptors, T cells comprising the same, and methods of using the same
|
|
WO2012054825A1
(en)
|
2010-10-22 |
2012-04-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mage-a3 t cell receptors and related materials and methods of use
|
|
CN102827272B
(zh)
*
|
2010-11-08 |
2014-04-02 |
上海汉升生物科技有限公司 |
一种叶酸偶联抗体药物及其制备方法与应用
|
|
WO2012076059A1
(en)
|
2010-12-09 |
2012-06-14 |
Stichting Het Nederlands Kanker Instituut |
Immune restricted peptides with increased efficacy
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
EP2651442B1
(en)
|
2010-12-14 |
2020-04-22 |
University of Maryland, Baltimore |
Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer
|
|
WO2012099973A2
(en)
|
2011-01-18 |
2012-07-26 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating cancer
|
|
SG193023A1
(en)
|
2011-02-11 |
2013-10-30 |
Sloan Kettering Inst Cancer |
Hla-restricted, peptide-specific antigen binding proteins
|
|
CN110200997A
(zh)
|
2011-03-23 |
2019-09-06 |
弗雷德哈钦森癌症研究中心 |
用于细胞免疫治疗的方法和组合物
|
|
EP2502934B1
(en)
|
2011-03-24 |
2018-01-17 |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz |
Single chain antigen recognizing constructs (scARCs) stabilized by the introduction of novel disulfide bonds
|
|
EA201391449A1
(ru)
|
2011-04-01 |
2014-03-31 |
Мемориал Слоан-Кеттеринг Кэнсер Сентер |
Антитела против пептидов цитозоля
|
|
ES2872077T3
(es)
|
2011-04-08 |
2021-11-02 |
Us Health |
Receptor de antígenos quiméricos anti-variante III del receptor de factor de crecimiento epidérmico y uso de los mismos para el tratamiento de cáncer
|
|
CN103502439B
(zh)
|
2011-04-13 |
2016-10-12 |
因缪尼卡姆股份公司 |
用于抗原特异性t细胞增殖的方法
|
|
JP2014511704A
(ja)
|
2011-04-13 |
2014-05-19 |
イミュニカム・エイビイ |
Ｔ細胞のプライミングのための方法
|
|
ES2666550T3
(es)
|
2011-04-19 |
2018-05-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anticuerpos monoclonales humanos específicos para glipicano 3 y uso de los mismos
|
|
GB201108236D0
(en)
|
2011-05-17 |
2011-06-29 |
Ucl Business Plc |
Method
|
|
ES2888651T3
(es)
|
2011-07-29 |
2022-01-05 |
Univ Pennsylvania |
Receptores de conmutación coestimulantes
|
|
MX356947B
(es)
|
2011-08-23 |
2018-06-20 |
Roche Glycart Ag |
Anticuerpos bioespecíficos específicos para antígenos que activan células t y un antígeno tumoral y métodos de uso.
|
|
US9833476B2
(en)
|
2011-08-31 |
2017-12-05 |
The Trustees Of Dartmouth College |
NKP30 receptor targeted therapeutics
|
|
PT2755997T
(pt)
|
2011-09-15 |
2018-10-30 |
Us Health |
Recetores de célula t que reconhecem mage restrito a hlaa1 ou hla-cw7
|
|
SG11201400527XA
(en)
|
2011-09-16 |
2014-04-28 |
Univ Pennsylvania |
Rna engineered t cells for the treatment of cancer
|
|
US20140255363A1
(en)
|
2011-09-16 |
2014-09-11 |
Baylor College Of Medicine |
Targeting the tumor microenvironment using manipulated nkt cells
|
|
US9708384B2
(en)
|
2011-09-22 |
2017-07-18 |
The Trustees Of The University Of Pennsylvania |
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
|
|
JP6053688B2
(ja)
|
2011-10-07 |
2016-12-27 |
国立大学法人三重大学 |
キメラ抗原受容体
|
|
US9868774B2
(en)
|
2011-10-20 |
2018-01-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD22 chimeric antigen receptors
|
|
JP6074435B2
(ja)
|
2011-10-26 |
2017-02-01 |
ナショナル キャンサー センター |
変異ｃｔｌａ４遺伝子移入ｔ細胞及びこれを含む抗がん免疫治療用組成物
|
|
WO2013063019A1
(en)
|
2011-10-28 |
2013-05-02 |
The Wistar Institute Of Anatomy And Biology |
Methods and compositions for enhancing the therapeutic effect of anti-tumor t cells
|
|
WO2013063419A2
(en)
|
2011-10-28 |
2013-05-02 |
The Trustees Of The University Of Pennsylvania |
A fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
|
|
ES2861435T3
(es)
|
2011-11-03 |
2021-10-06 |
Univ Pennsylvania |
Composiciones específicas de B7-H4 aisladas y métodos de uso de las mismas
|
|
US20140322216A1
(en)
|
2011-11-08 |
2014-10-30 |
The Trustees Of The University Of Pennsylvania |
Glypican-3-specific antibody and uses thereof
|
|
ES2687954T3
(es)
|
2011-11-11 |
2018-10-30 |
Fred Hutchinson Cancer Research Center |
Inmunoterapia de linfocitos T dirigidos a ciclina A1 contra el cáncer
|
|
BR112014014105B1
(pt)
*
|
2011-12-16 |
2023-10-10 |
Targetgene Biotechnologies Ltd |
Método para modificar um sítio-alvo predeterminado no interior de um ácido nucleico genômico ou organelar alvo em uma célula hospedeira eucariótica por um complexo núcleoproteína
|
|
CA2859755C
(en)
|
2011-12-23 |
2021-04-20 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
EP2807194A4
(en)
|
2012-01-27 |
2015-12-02 |
Gliknik Inc |
FUSION PROTEINS WITH IGG2 HINGEOMS
|
|
EP3594245A1
(en)
|
2012-02-13 |
2020-01-15 |
Seattle Children's Hospital d/b/a Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
|
CA3205751A1
(en)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Use of icos-based cars to enhance antitumor activity and car persistence
|
|
WO2013126726A1
(en)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Double transgenic t cells comprising a car and a tcr and their methods of use
|
|
SG11201404284SA
(en)
|
2012-02-22 |
2014-10-30 |
Univ Pennsylvania |
Use of the cd2 signaling domain in second-generation chimeric antigen receptors
|
|
CA3116051C
(en)
|
2012-03-23 |
2023-09-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin chimeric antigen receptors
|
|
MX394639B
(es)
*
|
2012-04-11 |
2025-03-24 |
Us Health |
Receptores del antigeno quimerico que seleccionan el antigeno para la maduracion de las celulas b
|
|
US9156915B2
(en)
|
2012-04-26 |
2015-10-13 |
Thomas Jefferson University |
Anti-GCC antibody molecules
|
|
RU2018130123A
(ru)
|
2012-05-03 |
2018-11-07 |
Фред Хатчинсон Кансэр Рисёч Сентер |
Клетка, экспрессирующая t-клеточный рецептор (tcr), для применения в клеточной иммунотерапии
|
|
JP6389166B2
(ja)
|
2012-05-07 |
2018-09-12 |
トラスティーズ・オブ・ダートマス・カレッジ |
抗ｂ７−ｈ６抗体、融合タンパク質、及びこれらを使用する方法
|
|
WO2013177247A1
(en)
|
2012-05-22 |
2013-11-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Murine anti-ny-eso-1 t cell receptors
|
|
US8952169B2
(en)
|
2012-05-22 |
2015-02-10 |
Xenon Pharmaceuticals Inc. |
N-substituted benzamides and methods of use thereof
|
|
DK3473707T3
(da)
|
2012-05-25 |
2025-03-17 |
Cellectis |
Fremgangsmåder til engineering af allogen og immunsuppressiv resistent t-celle til immunoterapi
|
|
US9409994B2
(en)
|
2012-06-01 |
2016-08-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
High-affinity monoclonal antibodies to glypican-3 and use thereof
|
|
IN2015MN00001A
(enExample)
|
2012-06-08 |
2015-10-16 |
Univ Kinki |
|
|
JP5863585B2
(ja)
|
2012-07-11 |
2016-02-16 |
三菱電機株式会社 |
大信号等価回路モデルを用いたトランジスタ特性計算装置
|
|
AU2013289970A1
(en)
|
2012-07-13 |
2015-01-22 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for regulating CAR T cells
|
|
JP2015524255A
(ja)
|
2012-07-13 |
2015-08-24 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
二重特異性抗体を共導入することによってｃａｒｔ細胞の活性を強化する方法
|
|
WO2014011996A1
(en)
|
2012-07-13 |
2014-01-16 |
The Trustees Of The University Of Pennsylvania |
Methods of assessing the suitability of transduced t cells for administration
|
|
KR102204029B1
(ko)
|
2012-07-13 |
2021-01-19 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
Ｃａｒ의 항-종양 활성에 대한 독성 관리
|
|
CN102775500A
(zh)
|
2012-08-03 |
2012-11-14 |
郑骏年 |
嵌合抗原受体iRGD-scFv(G250)-CD8-CD28-CD137-CD3ζ及其用途
|
|
IL293944A
(en)
|
2012-08-20 |
2022-08-01 |
Hutchinson Fred Cancer Res |
Method and preparations for cellular immunotherapy
|
|
EP3327037B1
(en)
|
2012-08-21 |
2019-10-09 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Mesothelin domain-specific monoclonal antibodies and use thereof
|
|
WO2014039523A1
(en)
|
2012-09-04 |
2014-03-13 |
Cellectis |
Multi-chain chimeric antigen receptor and uses thereof
|
|
MX367279B
(es)
|
2012-09-14 |
2019-08-13 |
Us Health |
Receptores de la celula t que reconocen mhc de mage-a3 de calse ii-restringida.
|
|
US9416190B2
(en)
|
2012-09-27 |
2016-08-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin antibodies and methods for eliciting potent antitumor activity
|
|
US9365641B2
(en)
|
2012-10-01 |
2016-06-14 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting stromal cells for the treatment of cancer
|
|
CN104853766A
(zh)
|
2012-10-02 |
2015-08-19 |
纪念斯隆-凯特琳癌症中心 |
用于免疫疗法的组合物和方法
|
|
US10117896B2
(en)
|
2012-10-05 |
2018-11-06 |
The Trustees Of The University Of Pennsylvania |
Use of a trans-signaling approach in chimeric antigen receptors
|
|
US9598489B2
(en)
|
2012-10-05 |
2017-03-21 |
The Trustees Of The Univeristy Of Pennsylvania |
Human alpha-folate receptor chimeric antigen receptor
|
|
EP2906684B8
(en)
|
2012-10-10 |
2020-09-02 |
Sangamo Therapeutics, Inc. |
T cell modifying compounds and uses thereof
|
|
US20140120136A1
(en)
|
2012-10-12 |
2014-05-01 |
The Babraham Institute |
Mir-155 enhancement of cd8+ t cell immunity
|
|
UY35103A
(es)
|
2012-10-29 |
2014-05-30 |
Glaxo Group Ltd |
Compuestos de cefem 2-sustituidos
|
|
WO2014100615A1
(en)
|
2012-12-20 |
2014-06-26 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
AU2013204922B2
(en)
|
2012-12-20 |
2015-05-14 |
Celgene Corporation |
Chimeric antigen receptors
|
|
WO2014099671A1
(en)
|
2012-12-20 |
2014-06-26 |
Bluebird Bio, Inc. |
Chimeric antigen receptors and immune cells targeting b cell malignancies
|
|
US9511092B2
(en)
|
2013-01-28 |
2016-12-06 |
St. Jude Children's Research Hospital, Inc. |
Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease
|
|
NZ711807A
(en)
|
2013-02-06 |
2020-06-26 |
Celgene Corp |
Modified t lymphocytes having improved specificity
|
|
JO3529B1
(ar)
|
2013-02-08 |
2020-07-05 |
Amgen Res Munich Gmbh |
مضاد التصاق خلايا الدم البيض من أجل التخفيف من الاثار السلبية الممكنة الناتجة عن مجالات ارتباط cd3- المحدد
|
|
DK2956175T3
(da)
|
2013-02-15 |
2017-11-27 |
Univ California |
Kimærisk antigenreceptor og fremgangsmåder til anvendelse deraf
|
|
US9573988B2
(en)
|
2013-02-20 |
2017-02-21 |
Novartis Ag |
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells
|
|
CN111139256A
(zh)
|
2013-02-20 |
2020-05-12 |
诺华股份有限公司 |
使用人源化抗EGFRvIII嵌合抗原受体治疗癌症
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
US9499855B2
(en)
|
2013-03-14 |
2016-11-22 |
Elwha Llc |
Compositions, methods, and computer systems related to making and administering modified T cells
|
|
WO2014153164A1
(en)
|
2013-03-14 |
2014-09-25 |
The California Institute For Biomedical Research |
Targeting agent antibody conjugates and uses thereof
|
|
US9587237B2
(en)
|
2013-03-14 |
2017-03-07 |
Elwha Llc |
Compositions, methods, and computer systems related to making and administering modified T cells
|
|
US9402888B2
(en)
|
2013-03-14 |
2016-08-02 |
The Wistar Institute Of Anatomy And Biology |
Methods and compositions for treating cancer
|
|
WO2014151960A2
(en)
|
2013-03-14 |
2014-09-25 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
|
CA2907397C
(en)
|
2013-03-15 |
2022-11-22 |
Anthrogenesis Corporation |
Modified t lymphocytes
|
|
US9745368B2
(en)
|
2013-03-15 |
2017-08-29 |
The Trustees Of The University Of Pennsylvania |
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
|
|
US9561291B2
(en)
|
2013-03-15 |
2017-02-07 |
Imre Kovesdi |
Methods of targeting T-cells to tumors
|
|
US9446105B2
(en)
|
2013-03-15 |
2016-09-20 |
The Trustees Of The University Of Pennsylvania |
Chimeric antigen receptor specific for folate receptor β
|
|
US9393268B2
(en)
|
2013-03-15 |
2016-07-19 |
Thomas Jefferson University |
Cell-based anti-cancer compositions with reduced toxicity and methods of making and using the same
|
|
US9657105B2
(en)
|
2013-03-15 |
2017-05-23 |
City Of Hope |
CD123-specific chimeric antigen receptor redirected T cells and methods of their use
|
|
UY35468A
(es)
|
2013-03-16 |
2014-10-31 |
Novartis Ag |
Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
|
|
US9790282B2
(en)
|
2013-03-25 |
2017-10-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
|
|
ES2828982T3
(es)
|
2013-05-14 |
2021-05-28 |
Univ Texas |
Aplicación humana de células t de receptor de antígeno quimérico (car) diseñadas
|
|
HK1223401A1
(zh)
|
2013-05-15 |
2017-07-28 |
桑格摩生物科学股份有限公司 |
用於治疗遗传病状的方法和组合物
|
|
WO2014190273A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
ES2645393T3
(es)
|
2013-05-29 |
2017-12-05 |
Cellectis |
Métodos de manipulación de linfocitos T para inmunoterapia usando el sistema de nucleasa Cas guiada por ARN
|
|
ES2883131T3
(es)
|
2013-05-29 |
2021-12-07 |
Cellectis |
Métodos para la modificación de células T para inmunoterapia utilizando el sistema de nucleasa CAS guiado por ARN
|
|
EP3569253A1
(en)
|
2013-06-05 |
2019-11-20 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
|
WO2014200891A1
(en)
|
2013-06-11 |
2014-12-18 |
THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTEMENT OF HEALTH & HUMAN SERVICES |
Her2-specific monoclonal antibodies and conjugates thereof
|
|
WO2014209802A1
(en)
|
2013-06-25 |
2014-12-31 |
Vaccinex, Inc. |
Use of semaphorin-4d inhibitory molecules in combination with an immune modulating therapy to inhibit tumor growth and metastases
|
|
US9808486B2
(en)
|
2013-08-30 |
2017-11-07 |
Board Of Regents, The University Of Texas System |
Administration of kynurenine depleting enzymes for tumor therapy
|
|
WO2015038579A1
(en)
|
2013-09-11 |
2015-03-19 |
Equip, Llc |
Discrete peg based dyes
|
|
CN105813654B
(zh)
|
2013-10-11 |
2019-05-31 |
美国政府(由卫生和人类服务部的部长所代表) |
Tem8抗体及其用途
|
|
KR102357968B1
(ko)
|
2013-10-15 |
2022-02-03 |
더 스크립스 리서치 인스티튜트 |
키메라 항원 수용체 t 세포 스위치 및 이의 용도
|
|
AU2014337367B2
(en)
|
2013-10-15 |
2020-04-30 |
The Scripps Research Institute |
Peptidic chimeric antigen receptor T cell switches and uses thereof
|
|
US10144770B2
(en)
|
2013-10-17 |
2018-12-04 |
National University Of Singapore |
Chimeric receptors and uses thereof in immune therapy
|
|
NZ758715A
(en)
|
2013-10-31 |
2023-01-27 |
Seattle Children’S Hospital Dba Seattle Children’S Res Institute |
Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
|
|
US10526406B2
(en)
|
2014-01-14 |
2020-01-07 |
Cellectis |
Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish
|
|
US9694033B2
(en)
|
2014-01-24 |
2017-07-04 |
The Cleveland Clinic Foundation |
IL-9 secreting CD8+ Tc9 cells and methods of treating cancer
|
|
MX375123B
(es)
|
2014-02-14 |
2025-03-06 |
Immune Design Corp |
Composición para usarse en mejorar la respuesta inmune contra el cáncer.
|
|
CA2937750A1
(en)
|
2014-02-14 |
2015-08-20 |
Bellicum Pharmaceuticals, Inc. |
Methods for activating t cells using an inducible chimeric polypeptide
|
|
CA2977839C
(en)
|
2014-02-28 |
2022-07-26 |
The Royal Institution For The Advancement Of Learning / Mcgill University |
Tc-ptp inhibitors as apc activators for immunotherapy
|
|
KR101605421B1
(ko)
|
2014-03-05 |
2016-03-23 |
국립암센터 |
B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
|
|
GB201403875D0
(en)
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
CA2940460A1
(en)
|
2014-03-07 |
2015-09-11 |
Bellicum Pharmaceuticals, Inc. |
Caspase polypeptides having modified activity and uses thereof
|
|
ES2857226T3
(es)
|
2014-03-15 |
2021-09-28 |
Novartis Ag |
Receptor de antígeno quimérico regulable
|
|
LT3129470T
(lt)
|
2014-04-07 |
2021-07-12 |
Novartis Ag |
Vėžio gydymas naudojant anti-cd19 chimerinį antigeno receptorių
|
|
WO2015157299A2
(en)
|
2014-04-09 |
2015-10-15 |
Seattle Children's Hospital (Dba Seattle Children's Research Institute |
Inhibition of lactate dehydrogenase 5 (ldh-5) binding, incorporation, internalization and/or endocytosis to immune cells
|
|
US10611837B2
(en)
|
2014-04-10 |
2020-04-07 |
Seattle Children's Hospital |
Transgene genetic tags and methods of use
|
|
US20170158749A1
(en)
|
2014-04-23 |
2017-06-08 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) and methods for making and using the same
|
|
US10494422B2
(en)
|
2014-04-29 |
2019-12-03 |
Seattle Children's Hospital |
CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies
|
|
EP3155018A4
(en)
|
2014-06-06 |
2018-01-10 |
The California Institute for Biomedical Research |
Constant region antibody fusion proteins and compositions thereof
|
|
WO2015191874A1
(en)
|
2014-06-12 |
2015-12-17 |
Children's National Medical Center |
Generation of broadly-specific, virus-immune cells targeting multiple hiv antigens for preventive and therapeutic use
|
|
JP7054622B2
(ja)
|
2014-07-21 |
2022-04-14 |
ノバルティス アーゲー |
ヒト化抗ｂｃｍａキメラ抗原受容体を使用した癌の処置
|
|
SG10201913765YA
(en)
|
2014-07-21 |
2020-03-30 |
Novartis Ag |
Treatment of cancer using a cd33 chimeric antigen receptor
|
|
CN107109420A
(zh)
|
2014-07-21 |
2017-08-29 |
诺华股份有限公司 |
使用cll－1嵌合抗原受体的癌症治疗
|
|
ES2819451T3
(es)
|
2014-08-08 |
2021-04-16 |
Univ Leland Stanford Junior |
Agentes PD-1 de alta afinidad y procedimientos de uso
|
|
US11141494B2
(en)
|
2014-08-09 |
2021-10-12 |
Purdue Research Foundation |
Development of neurokinin-1 receptor-binding agent delivery conjugates
|
|
CN106795497A
(zh)
|
2014-08-12 |
2017-05-31 |
人类起源公司 |
被工程化以归巢至淋巴结b细胞区、皮肤或胃肠道的car‑t淋巴细胞
|
|
AU2015305531B2
(en)
|
2014-08-19 |
2021-05-20 |
Novartis Ag |
Anti-CD123 chimeric antigen receptor (CAR) for use in cancer treatment
|
|
CA2959168A1
(en)
|
2014-09-02 |
2016-03-10 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
|
RU2749922C2
(ru)
|
2014-09-19 |
2021-06-21 |
Сити Оф Хоуп |
Т-КЛЕТКИ С КОСТИМУЛИРУЮЩИМ ХИМЕРНЫМ АНТИГЕННЫМ РЕЦЕПТОРОМ, НАЦЕЛЕННЫЕ НА IL13Rα2
|
|
WO2016054520A2
(en)
|
2014-10-03 |
2016-04-07 |
The California Institute For Biomedical Research |
Engineered cell surface proteins and uses thereof
|
|
EP3204399B1
(en)
|
2014-10-09 |
2025-01-22 |
Seattle Children's Hospital, dba Seattle Children's Research Institute |
Long poly (a) plasmids and methods for introduction of long poly (a) sequences into the plasmid
|
|
JP6613312B2
(ja)
|
2014-10-14 |
2019-11-27 |
ジ ユナイテッド ステイツ オブ アメリカ アズ リプリゼンティッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシズ |
膵臓癌を処置するためのペプチドをベースとする方法
|
|
CA2964392A1
(en)
|
2014-10-31 |
2016-05-06 |
Massachussetts Institute Of Technology |
Delivery of biomolecules to immune cells
|
|
JP2017535284A
(ja)
|
2014-11-05 |
2017-11-30 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
免疫エフェクター細胞の拡大のための遺伝子改変免疫エフェクター細胞及び遺伝子操作細胞
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
CA2964138C
(en)
|
2014-11-14 |
2023-11-14 |
Massachusetts Institute Of Technology |
Disruption and field enabled delivery of compounds and compositions into cells
|
|
MX381235B
(es)
|
2014-11-17 |
2025-03-12 |
Cellectar Biosciences Inc |
Análogos de éter fosfolipídico como portadores de fármacos dirigidos a cáncer.
|
|
KR20180041087A
(ko)
|
2014-12-02 |
2018-04-23 |
프로스펙트 차터케어 알더블유엠씨, 엘엘씨 디/비/에이 로저 윌리암스 메디컬 센터 |
암을 치료하기 위한 방법 및 조성물
|
|
AU2015357485B2
(en)
|
2014-12-05 |
2020-10-15 |
City Of Hope |
CS1 targeted chimeric antigen receptor-modified T cells
|
|
EP3234145B1
(en)
|
2014-12-15 |
2019-06-05 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlled activation or elimination of therapeutic cells
|
|
SI3240805T1
(sl)
|
2014-12-15 |
2025-04-30 |
The Regents Of The University Of California |
Bispecifični or-gate himerni antigenski receptor, odziv na cd19 in cd20
|
|
CA2966234A1
(en)
|
2014-12-15 |
2016-06-23 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlled elimination of therapeutic cells
|
|
US20190054117A1
(en)
|
2014-12-19 |
2019-02-21 |
Novartis Ag |
Dimerization switches and uses thereof
|
|
CN114107212A
(zh)
|
2014-12-24 |
2022-03-01 |
奥托路斯有限公司 |
细胞
|
|
CA2972597A1
(en)
|
2014-12-29 |
2016-07-07 |
Novartis Ag |
Methods of making chimeric antigen receptor-expressing cells
|
|
CA2972806A1
(en)
|
2014-12-31 |
2016-07-07 |
Anthrogenesis Corporation |
Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
|
|
US9765330B1
(en)
|
2015-01-09 |
2017-09-19 |
Nant Holdings Ip, Llc |
Compositions and methods for reduction of allograft recognition and rejection
|
|
WO2016138034A1
(en)
|
2015-02-24 |
2016-09-01 |
The Regents Of The University Of California |
Binding-triggered transcriptional switches and methods of use thereof
|
|
EP3549612B1
(en)
|
2015-03-02 |
2025-04-30 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Reducing immune tolerance induced by pd-l1
|
|
CN107708710A
(zh)
|
2015-03-17 |
2018-02-16 |
嵌合体生物工程公司 |
Smart CAR装置,DE CAR多肽,Side CAR及其使用
|
|
CA2984624A1
(en)
|
2015-03-18 |
2016-09-22 |
Baylor College Of Medicine |
Her2/erbb2 chimeric antigen receptor
|
|
US9717745B2
(en)
|
2015-03-19 |
2017-08-01 |
Zhejiang DTRM Biopharma Co. Ltd. |
Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
|
|
WO2016154628A1
(en)
|
2015-03-26 |
2016-09-29 |
Xiuli Wang |
Bi-specific targeted chimeric antigen receptor t cells
|
|
WO2016154621A1
(en)
|
2015-03-26 |
2016-09-29 |
The California Institute For Biomedical Research |
SWITCHABLE NON-scFv CHIMERIC RECEPTORS, SWITCHES, AND USES THEREOF
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
WO2016168769A1
(en)
|
2015-04-15 |
2016-10-20 |
The California Institute For Biomedical Research |
Chimeric receptor t cell switches for her2
|
|
WO2016168773A2
(en)
|
2015-04-15 |
2016-10-20 |
The California Institute For Biomedical Research |
Optimized pne-based chimeric receptor t cell switches and uses thereof
|
|
AU2016265845B2
(en)
|
2015-05-15 |
2020-10-08 |
City Of Hope |
Chimeric antigen receptor compositions
|
|
AU2016264363B2
(en)
|
2015-05-19 |
2019-07-25 |
Tuhura Biosciences, Inc. |
Cancer vaccine comprising mRNA encoding a M-like-protein
|
|
HK1246151A1
(zh)
|
2015-05-28 |
2018-09-07 |
凯德药业股份有限公司 |
为t细胞疗法而调理患者的方法
|
|
CN107708741A
(zh)
|
2015-06-12 |
2018-02-16 |
免疫医疗公司 |
用嵌合抗原受体(car)构建体和表达car构建体的t细胞(car‑t)或nk细胞(car‑nk)进行的疾病疗法
|
|
US9663756B1
(en)
|
2016-02-25 |
2017-05-30 |
Flodesign Sonics, Inc. |
Acoustic separation of cellular supporting materials from cultured cells
|
|
GB201514328D0
(en)
|
2015-08-12 |
2015-09-23 |
Sigmoid Pharma Ltd |
Compositions
|
|
GB201514874D0
(en)
|
2015-08-20 |
2015-10-07 |
Autolus Ltd |
Cell
|
|
GB201514875D0
(en)
|
2015-08-20 |
2015-10-07 |
Autolus Ltd |
Receptor
|
|
WO2017035362A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Use of complement pathway inhibitor compounds to mitigate adoptive t-cell therapy associated adverse immune responses
|
|
CA2997912A1
(en)
|
2015-09-09 |
2017-03-16 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Genetic engineering of macrophages for immunotherapy
|
|
US9790467B2
(en)
|
2015-09-22 |
2017-10-17 |
Qt Holdings Corp |
Methods and compositions for activation or expansion of T lymphocytes
|
|
AU2016333898B2
(en)
|
2015-10-05 |
2020-11-12 |
Precision Biosciences, Inc. |
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
|
|
ES2809550T3
(es)
|
2015-10-06 |
2021-03-04 |
Hope City |
Receptores de antígenos quiméricos dirigidos contra PSCA
|
|
GB201518817D0
(en)
|
2015-10-23 |
2015-12-09 |
Autolus Ltd |
Cell
|
|
GB201518816D0
(en)
|
2015-10-23 |
2015-12-09 |
Autolus Ltd |
Receptor
|
|
AU2016349482A1
(en)
|
2015-11-05 |
2018-05-24 |
City Of Hope |
Methods for preparing cells for adoptive T cell therapy
|
|
WO2017083274A1
(en)
|
2015-11-09 |
2017-05-18 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Novel rna-based vector system for transient and stable gene expression
|
|
TWI724056B
(zh)
|
2015-11-19 |
2021-04-11 |
美商卡默森屈有限公司 |
Ｃｘｃｒ２抑制劑
|
|
TWI734715B
(zh)
|
2015-11-19 |
2021-08-01 |
美商卡默森屈有限公司 |
趨化因子受體調節劑
|
|
CA3007473A1
(en)
|
2015-12-14 |
2017-06-22 |
Bellicum Pharmaceuticals, Inc. |
Dual controls for therapeutic cell activation or elimination
|
|
US9849092B2
(en)
|
2015-12-21 |
2017-12-26 |
Gholam A. Peyman |
Early cancer detection and enhanced immunotherapy
|
|
EA201891589A1
(ru)
|
2016-01-08 |
2019-01-31 |
Те Риджентс Оф Те Юниверсити Оф Калифорния |
Условно активные гетеродимерные полипептиды и способы их применения
|
|
NZ743983A
(en)
|
2016-01-11 |
2025-08-29 |
Univ Leland Stanford Junior |
Chimeric proteins and methods of regulating gene expression
|
|
US10919950B2
(en)
|
2016-01-14 |
2021-02-16 |
Seattle Children's Hospital |
Tumor-specific IFNA secretion by car T-cells to reprogram the solid tumor microenvironment
|
|
AU2017213661B2
(en)
|
2016-02-05 |
2022-06-02 |
City Of Hope |
Administration of engineered T cells for treatment of cancers in the central nervous system
|
|
GB201602571D0
(en)
|
2016-02-12 |
2016-03-30 |
Autolus Ltd |
Signalling system
|
|
GB201602563D0
(en)
|
2016-02-12 |
2016-03-30 |
Autolus Ltd |
Signalling system
|
|
AU2017219859A1
(en)
|
2016-02-16 |
2018-08-09 |
Dana-Farber Cancer Institute, Inc. |
Immunotherapy compositions and methods
|
|
EP3416690A4
(en)
|
2016-02-19 |
2020-02-19 |
City of Hope |
BISPECIFIC APTAMER
|
|
US11111505B2
(en)
|
2016-03-19 |
2021-09-07 |
Exuma Biotech, Corp. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
|
BR112018069075A2
(pt)
|
2016-03-19 |
2019-01-29 |
F1 Oncology, Inc. |
métodos e composições para transduzir linfócitos e expansão regulada dos mesmos
|
|
RU2018136877A
(ru)
|
2016-03-22 |
2020-04-22 |
СИЭТЛ ЧИЛДРЕН'С ХОСПИТАЛ (ДиБиЭй СИЭТЛ ЧИЛДРЕН'С РИСЕРЧ ИНСТИТЬЮТ) |
Способы раннего вмешательства для профилактики или улучшения состояния токсичности
|
|
US12144850B2
(en)
|
2016-04-08 |
2024-11-19 |
Purdue Research Foundation |
Methods and compositions for car T cell therapy
|
|
WO2017180587A2
(en)
|
2016-04-11 |
2017-10-19 |
Obsidian Therapeutics, Inc. |
Regulated biocircuit systems
|
|
EP4628094A2
(en)
|
2016-06-06 |
2025-10-08 |
City of Hope |
Baff-r antibodies and uses thereof
|
|
KR102522419B1
(ko)
|
2016-06-06 |
2023-04-17 |
시티 오브 호프 |
Baff-r 표적 키메라 항원 수용체-변형된 t 세포 및 그 용도
|
|
GB201610512D0
(en)
|
2016-06-16 |
2016-08-03 |
Autolus Ltd |
Chimeric antigen receptor
|
|
GB201610515D0
(en)
|
2016-06-16 |
2016-08-03 |
Autolus Ltd |
Cell
|
|
US9567399B1
(en)
|
2016-06-20 |
2017-02-14 |
Kymab Limited |
Antibodies and immunocytokines
|
|
US11555177B2
(en)
|
2016-07-13 |
2023-01-17 |
President And Fellows Of Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
|
CA3033512A1
(en)
|
2016-08-09 |
2018-02-15 |
City Of Hope |
Chimeric poxvirus compositions and uses thereof
|
|
US9642906B2
(en)
|
2016-09-16 |
2017-05-09 |
Baylor College Of Medicine |
Generation of HPV-specific T-cells
|
|
US20190247500A1
(en)
|
2016-10-19 |
2019-08-15 |
City Of Hope |
Use of Triplex CMV Vaccine in CAR T Cell Therapy
|
|
US11116834B2
(en)
|
2016-10-19 |
2021-09-14 |
City Of Hope |
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy
|
|
KR102613430B1
(ko)
|
2016-10-19 |
2023-12-18 |
더 스크립스 리서치 인스티튜트 |
인간화된 표적화 모이어티 및/또는 최적화된 키메라 항원 수용체-상호작용 도메인을 갖는 키메라 항원 수용체 효과기 세포 스위치 및 이의 용도
|
|
US10617720B2
(en)
|
2016-10-20 |
2020-04-14 |
Miltenyi Biotech, GmbH |
Chimeric antigen receptor specific for tumor cells
|
|
EP4644554A2
(en)
|
2016-10-31 |
2025-11-05 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
Method for treating autoimmune disease using cd4 t-cells with engineered stabilization of expression of endogenous foxp3 gene
|
|
US20200095547A1
(en)
|
2016-12-02 |
2020-03-26 |
Darya ALIZADEH |
Methods for manufacturing t cells expressing of chimeric antigen receptors and other receptors
|
|
CA3045665A1
(en)
|
2016-12-12 |
2018-06-21 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells
|
|
JP7206214B2
(ja)
|
2016-12-13 |
2023-01-17 |
シアトル チルドレンズ ホスピタル （ディービーエイ シアトル チルドレンズ リサーチ インスティテュート） |
インビトロ及びインビボで操作された細胞において発現された化学誘導シグナル伝達複合体の外因性薬物活性化の方法
|
|
EP3336107A1
(en)
|
2016-12-15 |
2018-06-20 |
Miltenyi Biotec GmbH |
Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor
|
|
JP7078937B2
(ja)
|
2016-12-21 |
2022-06-01 |
ダンマークス テクニスク ユニバーシテット |
免疫細胞を操作するための抗原提示足場
|
|
CA3051481A1
(en)
|
2017-02-07 |
2018-08-16 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Phospholipid ether (ple) car t cell tumor targeting (ctct) agents
|
|
EP3583218B1
(en)
|
2017-02-17 |
2025-04-16 |
Purdue Research Foundation |
Targeted ligand-payload based drug delivery for cell therapy
|
|
ES3010559T3
(en)
|
2017-02-28 |
2025-04-03 |
Endocyte Inc |
Compositions and methods for car t cell therapy
|
|
WO2018165198A1
(en)
|
2017-03-06 |
2018-09-13 |
University Of Washington |
Cell-based methods and compositions for therapeutic agent delivery and treatments using same
|
|
WO2018165194A1
(en)
|
2017-03-06 |
2018-09-13 |
University Of Washington |
Engineered cells and agent compositions for therapeutic agent delivery and treatments using same
|
|
US11939594B2
(en)
|
2017-03-16 |
2024-03-26 |
Seattle Children's Hospital |
Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins
|
|
EP3600352A1
(en)
|
2017-03-20 |
2020-02-05 |
City of Hope |
Cs1 targeted chimeric antigen receptor-modified t cells for treatment of al amyloidosis
|
|
WO2018213332A1
(en)
|
2017-05-17 |
2018-11-22 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Generating mammalian t cell activation inducible synthetic promoters (syn+pro) to improve t cell therapy
|
|
CN111246882A
(zh)
|
2017-08-01 |
2020-06-05 |
希望之城 |
抗il1rap抗体
|
|
WO2019033050A1
(en)
|
2017-08-11 |
2019-02-14 |
City Of Hope |
BISPECIFIC MOLECULE FOR BINDING TO ANTIGEN
|
|
JP7549303B2
(ja)
|
2018-01-22 |
2024-09-11 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞の使用方法
|
|
CN111936518A
(zh)
|
2018-02-06 |
2020-11-13 |
西雅图儿童医院（Dba西雅图儿童研究所） |
对fl-ple标记的肿瘤表现出最佳的t细胞功能的荧光素特异性car
|
|
CN112105382A
(zh)
|
2018-02-23 |
2020-12-18 |
恩多塞特公司 |
用于car t细胞疗法的顺序方法
|
|
JP7721436B2
(ja)
|
2018-04-12 |
2025-08-12 |
ウモジャ バイオファーマ インコーポレイテッド |
ウイルスベクター及びパッケージング細胞株
|
|
CA3091490A1
(en)
|
2018-04-27 |
2019-10-31 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Rapamycin resistant cells
|
|
CN112789051A
(zh)
|
2018-08-06 |
2021-05-11 |
西雅图儿童医院（Dba西雅图儿童研究所） |
用半抗原标记的细胞刺激嵌合抗原受体t细胞的方法和组合物
|
|
JP7623935B2
(ja)
|
2018-08-07 |
2025-01-29 |
パーデュー・リサーチ・ファウンデーション |
Ｃａｒ ｔ細胞の若返り
|
|
WO2020106992A1
(en)
|
2018-11-21 |
2020-05-28 |
Umoja Biopharma, Inc. |
Multicistronic vector for surface engineering lentiviral particles
|
|
EP3993814A4
(en)
|
2019-07-05 |
2023-06-28 |
Purdue Research Foundation |
Design and efficient synthesis of lipid-fluorescein conjugates for car-t cell therapy
|
|
MX2022003215A
(es)
|
2019-09-17 |
2022-04-25 |
Purdue Research Foundation |
Formacion de imagenes especificas para proteina de activacion de fibroblastos (fap) y terapia contra tipos de cancer y otras enfermedades fibroticas e inflamatorias.
|
|
US20240122978A1
(en)
|
2019-10-16 |
2024-04-18 |
Umoja Biopharma, Inc. |
Retroviral vector for univeral receptor therapy
|
|
CA3165713A1
(en)
|
2020-01-30 |
2021-08-05 |
Andrew Scharenberg |
Bispecific transduction enhancer
|
|
JP7744914B2
(ja)
|
2020-02-04 |
2025-09-26 |
シアトル チルドレンズ ホスピタル ディー／ビー／エイ シアトル チルドレンズ リサーチ インスティテュート |
ハプテン標識細胞によりキメラ抗原受容体ｔ細胞を刺激する方法およびそのための組成物
|
|
EP4100428A4
(en)
|
2020-02-04 |
2024-03-06 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
CHIMERIC ANTI-DINITROPHENOL ANTIGEN RECEPTORS
|
|
WO2021178887A1
(en)
|
2020-03-06 |
2021-09-10 |
Purdue Research Foundation |
Methods, compounds, and compositions for modifying car-t cell activity
|
|
CN116323656A
(zh)
|
2020-07-16 |
2023-06-23 |
优莫佳生物制药股份有限公司 |
门控衔接子靶向受体
|
|
MX2023005876A
(es)
|
2020-11-20 |
2023-07-20 |
Umoja Biopharma Inc |
Sistema de vector para administracion de multiples polinucleotidos y usos del mismo.
|
|
AU2022212952A1
(en)
|
2021-01-27 |
2023-08-10 |
Umoja Biopharma, Inc. |
Lentivirus for generating cells expressing anti-cd19 chimeric antigen receptor
|